Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-178585
Filing Date
2024-07-12
Accepted
2024-07-12 16:17:03
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d760581ds3.htm S-3 170084
2 EX-5.1 d760581dex51.htm EX-5.1 8928
3 EX-23.1 d760581dex231.htm EX-23.1 1751
4 EX-23.2 d760581dex232.htm EX-23.2 1520
5 EX-FILING FEES d760581dexfilingfees.htm EX-FILING FEES 31740
6 GRAPHIC g760581dsp30a.jpg GRAPHIC 3578
7 GRAPHIC g760581dsp30b.jpg GRAPHIC 17993
8 GRAPHIC g760581g28f59.jpg GRAPHIC 40449
9 GRAPHIC g760581g36q99.jpg GRAPHIC 55164
  Complete submission text file 0001193125-24-178585.txt   376881
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280784 | Film No.: 241114671
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)